Inlay an option for presbyopia at corneal level

Article

Data, presented by Prof. Grabner, reveals a corneal inlay has provided safe, effective and stable improvement of near and intermediate vision in emmetropic presbyopes over 5 years.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
An image of an iris placed over a digital interlay. Concept image for BVI Medical and VirtuaLens new technologies at European Society of Cataract and Refractive Surgeons meeting in Copenhagen, Denmark. (Image credit: ©spainter_vfx/AdobeStock)

BVI, VirtuaLens will showcase new technologies at ESCRS 2025

Kassi Filkins
September 18th 2025
Article
Upcoming company presentations from Alcon, J&J, B+L at ESCRS 2025

Upcoming company presentations from Alcon, J&J, B+L at ESCRS 2025

Kassi Filkins
September 18th 2025
Article
Concept image for the balancing of energy efficiency and time in refractive surgery phacoemulsification. A scale, with a laser beam of blue light on one side, and an analog alarm clock on the other side. The laser beam of blue light is surrounded by static. Created with Canva Magic AI.

Keys to optimising phaco efficiency

Marta Ibarz, MD, PhD
September 18th 2025
Article
Logos for Alcon, STAAR Surgical and the EVO ICL, on a turquoise background. Images courtesy of Alcon and STAAR Surgical.

Alcon announces acquisition of STAAR Surgical, EVO ICL lenses

Martin David Harp
September 18th 2025
Article
Frank Kerkhoff, MD, PhD, and visual acuity charts following implantation with the Johnson and Johnson Tecnis Odyssey lens.

Q&A: Early research findings and clinical experiences with a new multifocal IOL

Frank Kerkhoff, MD, PhD ;Hattie Hayes
September 18th 2025
Article
A row of beakers with yellow and orange fluid in a laboratory. Concept image for microbial lutein production, bioengineering, sustainable synthesis for cataract cornea age-related macular degeneration (AMD) and retinal disease. Image credit: bidala – stock.adobe.com

New microbial strain produces high yields of lutein for AMD, cataract prevention

Kassi Filkins
September 18th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.